Risk of Neutropenia With Clopidogrel
نویسنده
چکیده
1. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337: 581–8. 2. Bowen R, Glicklich A, Khan M, et al. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services Interim Public Health Recommendations. Morb Mortal Wkly Rep 1997;46:1061–6. 3. Burger AJ, Sherman HB, Charlamb MJ, et al. Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months. J Am Coll Cardiol 1999;34:1153–8. 4. Singh JP, Evans JC, Levy D, et al. Prevalence of valvular regurgitation in a population based cohort: Framingham heart study. Am J Cardiol 199;83:897–902.
منابع مشابه
Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition.
taking clopidogrel in CAPRIE from the neutropenia seen in .1% of patients treated with ticlopidine for greater than 1 month in whom profound life-threatening neutropenia develops requiring cessation of the drug and often requiring therapeutic interventions. This sort of severe neutropenia did not occur in any of the more than 9,000 patients in CAPRIE treated with clopidogrel and has been report...
متن کاملClopidogrel-Induced Recurrent Polyarthritis
Clopidogrel is an oral thienopyridine and together with aspirin is a component of dual antiplatelet therapy for the prevention of stent thrombosis after intracoronary stent placement. The common adverse effects from its use are an increased risk of bleeding, neutropenia, and rash. Arthralgia and backache are also known to occur with its use. There have been case reports linking arthritis with t...
متن کاملClopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also the use of clopidogrel is not without side effects. Clopidogrel major adverse events are represented by marrow suppression, manifesting with a...
متن کامل[Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation].
BACKGROUND Ticlopidine has been shown to reduce the incidence of stent thrombosis compared with warfarin, but it may cause serious hematological side effects. Clopidogrel, a new thienopyridine derivative, may be a safe alternative to ticlopidine. The aim of this study was to compare the safety and efficacy of clopidogrel and aspirin with those of ticlopidine and aspirin in patients undergoing c...
متن کاملEffectiveness of Clopidogrel and Aspirin Versus Ticlopidine and Aspirin in Preventing Stent Thrombosis After Coronary Stent Implantation
Background—Ticlopidine has been shown to reduce the incidence of stent thrombosis compared with warfarin, but it may cause serious hematological side effects. Clopidogrel, a new thienopyridine derivative, may be a safe alternative to ticlopidine. The aim of this study was to compare the safety and efficacy of clopidogrel and aspirin with those of ticlopidine and aspirin in patients undergoing c...
متن کاملThienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials.
BACKGROUND AND PURPOSE Aspirin is the most widely studied and prescribed antiplatelet drug for patients at high risk of vascular disease. We aimed to establish how the thienopyridines (ticlopidine and clopidogrel) compare with aspirin in terms of effectiveness and safety. METHODS We did a systematic review of all unconfounded randomized trials comparing either ticlopidine or clopidogrel with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016